Cooper Companies (COO) Gains from Investment Securities (2009 - 2026)
Cooper Companies (COO) recorded quarterly Gains from Investment Securities of -$30.2 million in Q2 2026, down 9.42% quarter-over-quarter from -$27.6 million in Q1 2026, and up 20.11% year-on-year from -$25.1 million in Q2 2025.
Cooper Companies (COO) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Gains from Investment Securities across 18 years of filings, most recently posting -$30.2 million for Q2 2026.
- For the quarter ending Q2 2026, Gains from Investment Securities rose 20.11% year-over-year to -$30.2 million; the trailing twelve-month figure through Apr 2026 stood at $41.1 million (up 402.21% YoY), and the FY2025 full-year result was $24.8 million, changed N/A from the prior year.
- Gains from Investment Securities was -$30.2 million for Q2 2026 at Cooper Companies, down from -$27.6 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $141.2 million in Q4 2025 and troughed at -$92.4 million in Q3 2023.
- The 5-year median for Gains from Investment Securities is -$27.4 million (2024), against an average of -$182352.9.
- Biggest YoY gain for Gains from Investment Securities was 860.87% in 2022; the steepest drop was 860.87% in 2022.
- Year by year, Gains from Investment Securities stood at $27.5 million in 2022, then surged by 399.27% to $137.3 million in 2023, then tumbled by 35.98% to $87.9 million in 2024, then jumped by 60.64% to $141.2 million in 2025, then plunged by 121.39% to -$30.2 million in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$30.2 million in Q2 2026, -$27.6 million in Q1 2026, and $141.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -30.20 Mn |
| Apr 30, 2026 | -30.20 Mn |
| Jan 31, 2026 | -27.60 Mn |
| Jan 31, 2026 | -27.60 Mn |
| Oct 31, 2025 | 141.20 Mn |
| Oct 31, 2025 | 141.20 Mn |
| Jul 31, 2025 | -42.30 Mn |
| Jul 31, 2025 | -42.30 Mn |
| Apr 30, 2025 | -37.80 Mn |
| Apr 30, 2025 | -37.80 Mn |
| Jan 31, 2025 | -36.30 Mn |
| Jan 31, 2025 | -36.30 Mn |
| Oct 31, 2024 | 87.90 Mn |
| Oct 31, 2024 | 87.90 Mn |
| Jul 31, 2024 | -27.40 Mn |
| Jul 31, 2024 | -27.40 Mn |
| Apr 30, 2024 | -35.10 Mn |
| Apr 30, 2024 | -35.10 Mn |
| Jan 31, 2024 | -25.40 Mn |
| Jan 31, 2024 | -25.40 Mn |